Capital International Investors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $44.6M | Sell |
|
|||||
|
2023
Q1 | $51.9M | Hold |
|
|||||
|
2022
Q4 | $60M | Sell |
|
|||||
|
2022
Q3 | $140M | Sell |
|
|||||
|
2022
Q2 | $204M | Buy |
|
|||||
|
2022
Q1 | $243M | Sell |
|
|||||
|
2021
Q4 | $452M | Sell |
|
|||||
|
2021
Q3 | $511M | Buy |
|
|||||
|
2021
Q2 | $520M | Buy |
|
|||||
|
2021
Q1 | $618M | Sell |
|
|||||
|
2020
Q4 | $867M | Buy |
|
|||||
|
2020
Q3 | $509M | Buy |
|
|||||
|
2020
Q2 | $476M | Sell |
|
|||||
|
2020
Q1 | $272M | Buy |
|
|||||
|
2019
Q4 | $258M | Buy |
|
|||||
|
2019
Q3 | $257M | Buy |
|
|||||
|
2019
Q2 | $357M | Buy |
|
|||||
|
2019
Q1 | $386M | Buy |
|
|||||
|
2018
Q4 | $200M | Buy |
|
|||||
|
2018
Q3 | $333M | Buy |
|
|||||
|
2018
Q2 | $277M | Buy |
|
|||||
|
2018
Q1 | $183M | Buy |
|
|||||
|
2017
Q4 | $166M | Buy |
|
|||||
|
2017
Q3 | $154M | Buy |
|
|||||
|
2017
Q2 | $148M | Buy |
|
|||||
|
2017
Q1 | $148M | Buy |
|
|||||
|
2016
Q4 | $70.4M | Buy |
|
|||||
|
2016
Q3 | $34.1M | Buy |
|